UAB’s ongoing research for countermeasures to bromine or chlorine exposure — from either industrial spills or chemical attack — gets a boost with a new NIH grant.
UAB’s Candace Floyd is set to take a top leadership post with the National Neurotrauma Society.
Haydeh Payami, Ph.D., a leading geneticist recruited to the UAB-Hudson Alpha Center for Genomic Medicine and UAB Personalized Medicine Institute, is exploring the protective power of coffee and nicotine — and the mysteries of the microbiome — in Parkinson’s disease.
Rates of vision impairment are high among seniors living in subsidized housing, suggesting an increased need for widespread vision screening.
Many patients diagnosed with type 1 diabetes as adults do not fit the standard profile for a diabetes diagnosis; they are younger, are relatively fit and have little if any belly fat.
The mimicry of bone cells by multiple myeloma is driven by overexpression of Runx2, the master regulator of bone formation.
UAB Hospital is the only Disease-Specific Certified program in Alabama and has had no observations or findings by The Joint Commission since joining the certification process.
The American College of Surgeons has again verified UAB as a Level I Trauma Center, a designation held by UAB since 1999.